Erratum: Regulatory T cells and innate immune regulation in tumor immunity (Springer Seminars in Immunopathology (2006) DOI: 10.1007/s00281-006-0022-7;Regulatory T cells and innate immune regulation in tumor immunity

Springer Seminars in Immunopathology

Volumn 28, Issue 1, 2006, Pages 17-23

  Wang, Rong Fu ^a,b,c  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b CENTER FOR CELL AND GENE THERAPY   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TOLL LIKE RECEPTOR;

ADOPTIVE TRANSFER; ANIMAL CELL; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; CARCINOGENESIS; CELL FUNCTION; CHRONIC INFLAMMATION; HOST PATHOGEN INTERACTION; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH; TUMOR IMMUNITY;

EID: 33747621828     PISSN: 03444325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00281-006-0044-1     Document Type: Erratum

References (100)

1. Boon T, Van der Bruggen P (1996) Human tumor antigens recognized by T lymphocytes. J Exp Med 183:725-729
2. Wang RF, Rosenberg SA (1999) Human tumor antigens for cancer vaccine development. Immunol Rev 170:85-100
3. Houghton AN, Gold JS, Blachere NE (2001) Immunity against cancer: lessons learned from melanoma. Curr Opin Immunol 13:134-140
4. Wang RF (2002) Enhancing antitumor immune responses: intracellular peptide delivery and identification of MHC class II-restricted tumor antigens. Immunol Rev 188:65-80
5. Rosenberg SA, Yang JC, Restifo NP (2004) Cancer immunotherapy: moving beyond current vaccines. Nat Med 10:909-915
6. Dudley ME, Wunderlich JR, Robbins PF et al (2002) Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 298:850-854
7. Pollard JW (2004) Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 4:71-78
8. Gabrilovich D (2004) Mechanisms and functional significance of tumour-induced dendritic-cell defects. Nat Rev Immunol 4:941-952
9. Wang RF, Peng G, Wang HY (2006) Regulatory T cells and Toll-like receptors in tumor immunity. Semin Immunol 18:136-142
10. Karin M, Greten FR (2005) NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5:749-759
11. Dunn GP, Old LJ, Schreiber RD (2004) The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21:137-148
12. Akira S, Takeda K (2004) Toll-like receptor signalling. Nat Rev Immunol 4:499-511
13. Steinman RM, Hawiger D, Nussenzweig MC (2003) Tolerogenic dendritic cells. Annu Rev Immunol 21:685-711
14. Zhang L, Conejo-Garcia JR, Katsaros D et al (2003) Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 348:203-213
15. Sato E, Olson SH, Ahn J et al (2005) Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci U S A 102:18538-18543
16. Curiel TJ, Coukos G, Zou L et al (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10:942-949
17. Yu P, Rowley DA, Fu YX et al (2006) The role of stroma in immune recognition and destruction of well-established solid tumors. Curr Opin Immunol 18(2):226-231
18. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860-867
19. Clevers H (2004) At the crossroads of inflammation and cancer. Cell 118:671-674
20. Condeelis J, Pollard JW (2006) Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 124:263-266
21. Greten FR, Eckmann L, Greten TF et al (2004) IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118:285-296
22. Roncarolo MG, Levings MK (2000) The role of different subsets of T regulatory cells in controlling autoimmunity. Curr Opin Immunol 12:676-683
23. Francois Bach J (2003) Regulatory T cells under scrutiny. Nat Rev Immunol 3:189-198
24. Weiner HL (2001) Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells. Immunol Rev 182:207-214
25. Sakaguchi S, Sakaguchi N, Shimizu J et al (2001) Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev 182:18-32
26. Wood KJ,Sakaguchi S (2003) Regulatory T cells in transplantation tolerance. Nat Rev Immunol 3:199-210
27. Hori S, Nomura T, Sakaguchi S (2003) Control of regulatory T cell development by the transcription factor foxp3. Science 299:1057-1061
28. Khattri R, Cox T, Yasayko SA et al (2003) An essential role for Scurfin in CD4(+)CD25(+) T regulatory cells. Nat Immunol 4:337-342
29. Fontenot JD, Gavin MA, Rudensky AY (2003) Foxp3 programs the development and function of CD4(+)CD25(+) regulatory T cells. Nat Immunol 4:330-336
30. Walker MR, Kasprowicz DJ, Gersuk VH et al (2003) Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25-T cells. J Clin Invest 112:1437-1443
31. Wang HY, Lee DA, Peng G et al (2004) Tumor-specific human CD4+ regulatory T cells and their ligands: implication for immunotherapy. Immunity 20:107-118
32. Fontenot JD, Rasmussen JP, Williams LM et al (2005) Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22:329-341
33. Wan YY, Flavell RA (2005) Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc Natl Acad Sci U S A 102:5126-5131
34. Shevach EM (2002) CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2:389-400
35. Shevach EM (2000) Regulatory T cells in autoimmmunity. Annu Rev Immunol 18:423-449
36. Belkaid Y, Piccirillo CA, Mendez S et al (2002) CD4+CD25+ regulatory T cells control leishmania major persistence and immunity. Nature 420:502-507
37. Sakaguchi S (2004) Naturally arising CD4+ regulatory T Cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22:531-562
38. Berendt MJ, North RJ (1980) T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor. J Exp Med 151:69-80
39. North RJ (1982) Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells. J Exp Med 155: 1063-1074
40. Mukherji B, Guha A, Chakraborty NG et al (1989) Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma. J Exp Med 169:1961-1976
41. Chakraborty NG, Twardzik DR, Sivanandham M et al (1990) Autologous melanoma-induced activation of regulatory T cells that suppress cytotoxic response. J Immunol 145:2359-2364
42. Woo EY, Chu CS, Goletz TJ et al (2001) Regulatory CD4(+) CD25(+) T cells in tumors from patients with early-stage nonsmall cell lung cancer and late-stage ovarian cancer. Cancer Res 61:4766-4772
43. Liyanage UK, Moore TT, Joo HG et al (2002) Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol 169:2756-2761
44. Viguier M, Lemaitre F, Verola O et al (2004) Foxp3 expressing CD4(+)CD25(high) regulatory T cells are over-represented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells. J Immunol 173:1444-1453
45. Wang HY, Peng G, Guo Z et al (2005) Recognition of a new ARTC1 peptide ligand uniquely expressed in tumor cells by antigen-specific CD4+ regulatory T cells. J Immunol 174:2661-2670
46. Sarantopoulos S, Lu L, Cantor H (2004) Qa-1 restriction of CD8 + suppressor T cells. J Clin Invest 114:1218-1221
47. Jiang H, Chess L (2004) An integrated view of suppressor T cell subsets in immunoregulation. J Clin Invest 114:1198-1208
48. Vlad G, Cortesini R, Suciu-Foca N (2005) License to heal: bidirectional interaction of antigen-specific regulatory T cells and tolerogenic APC. J Immunol 174:5907-5914
49. Jiang H, Chess L (2000) The specific regulation of immune responses by CD8+ T cells restricted by the MHC class Ib molecule, Qa-1. Annu Rev Immunol 18:185-216
50. Hu D, Ikizawa K, Lu L et al (2004) Analysis of regulatory CD8 T cells in Qa-1-deficient mice. Nat Immunol 5:516-523
51. Cantor H (2004) Reviving suppression? Nat Immunol 5:347-349
52. Sakaguchi S, Sakaguchi N, Asano M et al (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155:1151-1164
53. Hsieh CS, Liang Y, Tyznik AJ et al (2004) Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors. Immunity 21:267-277
54. Samy ET, Parker LA, Sharp CP et al (2005) Continuous control of autoimmune disease by antigen-dependent polyclonal CD4+ CD25+ regulatory T cells in the regional lymph node. J Exp Med 202:771-781
55. Suffia IJ, Reckling SK, Piccirillo CA et al (2006) Infected site-restricted Foxp3+ natural regulatory T cells are specific for microbial antigens. J Exp Med 203(3):777-788
56. Nishikawa H, Kato T, Tanida K et al (2003) CD4+ CD25+ T cells responding to serologically defined autoantigens suppress antitumor immune responses. Proc Natl Acad Sci U S A 100:10902-10906
57. Nishikawa H, Kato T, Tawara I et al (2005) Definition of target antigens for naturally occurring CD4(+) CD25(+) regulatory T cells. J Exp Med 201:681-686
58. Levings MK, Sangregorio R, Sartirana C et al (2002) Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells. J Exp Med 196:1335-1346
59. Dieckmann D, Bruett CH, Ploettner H et al (2002) Human CD4(+)CD25(+) regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells (corrected). J Exp Med 196:247-253
60. Jonuleit H, Schmitt E, Kakirman H et al (2002) Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells. J Exp Med 196:255-260
61. Chen W, Jin W, Hardegen N et al (2003) Conversion of peripheral CD4+CD25-naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198:1875-1886
62. Jordan MS, Boesteanu A, Reed AJ et al (2001) Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat Immunol 2:301-306
63. Cozzo C, Larkin J III, Caton AJ (2003) Cutting edge: self-peptides drive the peripheral expansion of CD4(+)CD25(+) regulatory T cells. J Immunol 171:5678-5682
64. Apostolou I, Sarukhan A, Klein L et al (2002) Origin of regulatory T cells with known specificity for antigen. Nat Immunol 3:756-763
65. Boonstra A, Asselin-Paturel C, Gilliet M et al (2003) Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: dependency on antigen dose and differential toll-like receptor ligation. J Exp Med 197:101-109
66. Apostolou I, Von Boehmer H (2004) In vivo instruction of suppressor commitment in naive T cells. J Exp Med 199:1401-1408
67. Kretschmer K, Apostolou I, Hawiger D et al (2005) Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 6(12):1219-1227
68. Chen Y, Kuchroo VK, Inobe J et al (1994) Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265:1237-1240
69. Jonuleit H, Schmitt E, Schuler G et al (2000) Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 192:1213-1222
70. Sundstedt A, O'Neill EJ, Nicolson KS et al (2003) Role for IL-10 in suppression mediated by peptide-induced regulatory T cells in vivo. J Immunol 170:1240-1248
71. Iwasaki A, Medzhitov R (2004) Toll-like receptor control of the adaptive immune responses. Nat Immunol 5:987-995
72. Takeda K, Akira S (2005) Toll-like receptors in innate immunity. Int Immunol 17:1-14
73. Heil F, Hemmi H, Hochrein H et al (2004) Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303:1526-1529
74. Diebold SS, Kaisho T, Hemmi H et al (2004) Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303:1529-1531
75. Lund JM, Alexopoulou L, Sato A et al (2004) Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc Natl Acad Sci U S A 101:5598-5603
76. Jurk M, Heil F, Vollmer J et al (2002) Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848. Nat Immunol 3:499
77. Caramalho I, Lopes-Carvalho T, Ostler D et al (2003) Regulatory T Cells selectively express Toll-like receptors and are activated by lipopolysaccharide. J Exp Med 197:403-411
78. Hemmi H, Kaisho T, Takeuchi O et al (2002) Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol 3:196-200
79. Crozat K, Beutler B (2004) TLR7: a new sensor of viral infection. Proc Natl Acad Sci U S A 101:6835-6836
80. Takaoka A, Yanai H, Kondo S et al (2005) Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 434:243-249
81. Honda K, Yanai H, Negishi H et al (2005) IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434:772-777
82. Honda K, Ohba Y, Yanai H et al (2005) Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature 434:1035-1040
83. Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124:783-801
84. Zheng SL, Augustsson-Balter K, Chang B et al (2004) Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the CAncer Prostate in Sweden Study. Cancer Res 64:2918-2922
85. Sun J, Wiklund F, Zheng SL et al (2005) Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk. J Natl Cancer Inst 97:525-532
86. Pikarsky E, Porat RM, Stein I et al (2004) NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 431:461-466
87. Luo JL, Maeda S, Hsu LC et al (2004) Inhibition of NF-kappaB in cancer cells converts inflammation-induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression. Cancer Cell 6:297-305
88. Maeda S, Kamata H, Luo JL et al (2005) IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 121:977-990
89. Karin M, Lawrence T, Nizet V (2006) Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell 124:823-835
90. Shimizu J, Yamazaki S, Sakaguchi S (1999) Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity. J Immunol 163:5211-5218
91. Sutmuller RP, van Duivenvoorde LM, van Elsas A et al (2001) Synergismof cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses. J Exp Med 194:823-832
92. Attia P, Maker AV, Haworth LR et al (2005) Inability of a fusion protein of IL-2 and diphtheria toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to eliminate regulatory T lymphocytes in patients with melanoma. J Immunother 28:582-592
93. Dannull J, Su Z, Rizzieri D et al (2005) Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells. J Clin Invest 115:3623-3633
94. Pasare C, Medzhitov R (2003) Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 299:1033-1036
95. Kubo T, Hatton RD, Oliver J et al (2004) Regulatory T cell suppression and anergy are differentially regulated by proinflammatory cytokines produced by TLR-activated dendritic cells. J Immunol 173:7249-7258
96. Fehervari Z, Sakaguchi S (2004) Control of Foxp3+ CD25+ CD4+ regulatory cell activation and function by dendritic cells. Int Immunol 16:1769-1780
97. Peng G, Guo Z, Kiniwa Y et al (2005) Toll-like receptor 8 mediated-reversal of CD4+ regulatory T cell function. Science 309:1380-1384
98. Crellin NK, Garcia RV, Hadisfar O et al (2005) Human CD4+ T cells express TLR5 and its ligand flagellin enhances the suppressive capacity and expression of FOXP3 in CD4+CD25+ T regulatory cells. J Immunol 175:8051-8059
99. Netea MG, Sutmuller R, Hermann C et al (2004) Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. J Immunol 172:3712-3718
100. Sutmuller RP, den Brok MH, Kramer M et al (2006) Toll-like receptor 2 controls expansion and function of regulatory T cells. J Clin Invest 116:485-494